Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Calabadions: New Broad-Spectrum Agents to Reverse Neuromuscular Blockade

Buscar en contenido

Contenido:

miércoles, 18 de diciembre de 2013

Glycocalix

PulmCCM - December 14, 2013 - By Phillipe Rola
"Ok, so I’d had a couple of glimpses at articles in the past few years which referred to the glycocalyx, but, in truth, I tend to read most of the “bench” studies a little, well…quickly. So basically, when I listened to Paul’s (Marik) recent lecture at Scott’s (Weingart, emcrit.org) New York Sepsis Collaborative, I started to dig a little…and whoa! And then of course, thennow famous expose by John (Doe?) on EmCrit continued to convince me that this is definitely something I need to pay attention to!
Its not like there hasn’t already been a high level of scrutiny of the glycocalyx in the field of sepsis. Google it. Its like a whole new world. It just hasn’t yet translated into an effective therapy, but nor has it seemed to spread into general awareness, and it seems like it’s high time it does, since it is the interface between the blood and the body – a “blood-body barrier” of sorts. So here we go, a crash course on the glycocalyx for the clinician in the trenches…" 
http://pulmccm.org/main/2013/critical-care-review/respect-glyocalyx-least-know-exists/
*
Life in the Fast Lane
http://lifeinthefastlane.com/education/ccc/glycocalyx-in-critical-illness/ 
*
EMCrit Blog
http://emcrit.org/blogpost/best-fluids-comment-ever/
*
Podcast 112
http://emcrit.org/podcasts/fluids-severe-sepsis/